MCD vs RARE · P/E 23, rev $25.92B vs rev $350.0M
McDonald’s Corporation (MCD) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. RARE currently screens at market cap $2.79B.
Not investment advice. Open the MCD and RARE stock pages for the full models.
Not investment advice.